General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients...

Asthma deaths levels increase by a quarter in a decade

Asthma deaths levels increase by a quarter in a decade

July 26 2018 There were 1,320 deaths due to asthma in England and Wales in 2017, the highest...

NPA and Age UK ask for help on building polypharmacy dossier

NPA and Age UK ask for help on building polypharmacy dossier

July 25 2018 The National Pharmacy Association is asking its members for case studies on...

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

July 24 2018 New Health Secretary Matt Hancock has called for investment in primary care and...

NHS Digital seeks views on SCR with Additional Information

NHS Digital seeks views on SCR with Additional Information

July 24 2018 A survey to assess the benefits and/or disadvantages of health professionals...

  • General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    Tuesday, 31 July 2018 15:31
  • Asthma deaths levels increase by a quarter in a decade

    Asthma deaths levels increase by a quarter in a decade

    Thursday, 26 July 2018 15:08
  • NPA and Age UK ask for help on building polypharmacy dossier

    NPA and Age UK ask for help on building polypharmacy dossier

    Wednesday, 25 July 2018 13:46
  • Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Tuesday, 24 July 2018 12:53
  • NHS Digital seeks views on SCR with Additional Information

    NHS Digital seeks views on SCR with Additional Information

    Tuesday, 24 July 2018 12:41

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

naloxoneOctober 29 2014

Approximately 59,500 people aged between 15 and 64 years in Scotland were identified with problem drug use in 2013-14.

The prevalence of 1.7% of the population is not a substantial change over recent years, says NHS Scotland’s Information Services Division. During 2012-13 the majority of individuals with problem drug use in Scotland were male (71%), with the highest rate among the 25-34 years age group.

There has been a slight fall in the rate of problem use in males aged 15-24 years and 25-34 years, but there was an increase in the rate of those aged 35-64 years, up from 43% in 2009-10 to 51% in 2012-13.

The data also shows prevalence rates for problem drug use tend to be higher in non-rural areas - Aberdeen, Dundee, Edinburgh and Glasgow are “well above” the Scottish rate, and Inverclyde, North Ayrshire, Renfrewshire and West Dumbartonshire are also higher than the Scottish rate. “These Council Areas serve some of the most deprived communities in Scotland according to the Scottish Index of Multiple Deprivation 2012.”

NHSISD has also issued data relating to the National Naloxone Programme and the number of naloxone kits that have been issued. The ‘take-home’ naloxone (THN) kits are issued in the community or by prisons prior to release.

In 2013-14 the number of THN kits issued increased 66.9% to 6,472 THN kits through the National Naloxone Programme. A total of 13,808 kits including those issued in the community and from prison were issued.

“The percentage of opioid-related deaths occurring within four weeks of prison release was 9.8% during 2006-10 (baseline period), compared to 8.4% in 2011, 5.5% in 2012 and 4.7% in 2013,” says the report. “This reduction coincides with the introduction of the National Naloxone Programme and distribution of kits to ‘at risk’ prisoners on liberation.

“The percentage of opioid-related deaths occurring within four weeks of a drug-related hospital discharge was 9.7% during 2006-10 (baseline). This figure fluctuated around the same level in 2011 (10%), 2012 (7%) and 2013 (10%). Currently the National Naloxone Programme is not implemented within the hospital setting, but there would be potential benefits to co-ordinated naloxone distribution from hospitals, especially for older and female high-risk opioid users.”

Community Safety Minister Roseanna Cunningham said: “One drug related death is one too many. Our world leading programme for take home naloxone, alongside life-saving training sends a clear message that lives matter, and will help those who may not have engaged with drugs services before.

“While problem drug use among the general adult population and young people has decreased, there is still an older group of people who now also face a range of other health problems placing them at increased risk of overdose and death. We are determined to tackle this and support these vulnerable people. The naloxone programme is a key part of this.

Dave Liddell, Director of Scottish Drugs Forum added: ““The latest figures highlight the excellent work being undertaken across Scotland to ensure that as far as possible, naloxone is available in every case when an opiate overdose is witnessed.

“The evidence suggest that 10% of the naloxone that is supplied will be used to reverse an overdose and it therefore vital that – even with these very encouraging figures – we continue to encourage naloxone distribution and training in its use, to become a standard part of what services offer to people who use opiates.”

Links:

NHS ISD statement on prevalence of problem drug use in Scotland

NHS ISD statement on National Naloxone Programme

Scottish Government statement

Practice News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...